<DOC>
	<DOC>NCT03021213</DOC>
	<brief_summary>Enhanced external counterpulsation (EECP) is an outpatient coronary artery disease (CAD) therapy that involves the cyclical inflation/deflation of cuffs wrapped around the lower extremities. However, the possible benefits of EECP in patients with heart failure (HF) (New York Heart Association [NYHA] classes II to IV) and cardiomyopathy are unclear.</brief_summary>
	<brief_title>Treating Heart Failure With Enhanced External Counterpulsation (EECP)</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Patients with heart failure (NYHA IIIV) 1. with optimal medical therapy 2. caused by ischemic or nonischemic cardiomyopathy EECPTherapy and Treatment in the Cardio Centrum Berlin or Charité University Medicine Berlin Aged 18 to 100 years Offered patient information and written informed consent Participation in another interventional trial Acute coronary syndrome &lt; 4 weeks prior to enrollment Operation &lt; 4 weeks prior to enrollment Stroke &lt; 4 weeks prior to enrollment Clinically significant disease with hospitalization Aortic valvular heart disease ≥ moderate Aortic aneurysm clinically relevant severe cardiopulmonal diseases Resting RR &gt; 160/90mmHg Thrombose, Thrombophlebitis &lt; 8 weeks prior to enrollment Peripheral artery occlusive disease ≥ Stadium II Acute Heart failure Pathological bleeding tendency Arrhythmias, which interfere with Triggering of the EECP Other diseases, that inhibit EECPTreatment (e.g. Spinal disc herniation) Accommodation in an institution due to an official or judicial order Women: pregnancy or lactation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>